Company profilePharmaceutical#663 of 1,318 in Pakistan✓ No DRAP alerts

Hakimsons Private Limited

Pharmaceutical company · 15 brands · 18 molecules

Ranked #1 of 12 companies in Immune Sera And Immunoglobulins

15 registered products 15 pharmaceutical brands 18 distinct molecules 0 DRAP alerts

Company overview

15
registered products
15
pharmaceutical brands
18
distinct molecules
3
therapeutic classes
0
DRAP alerts

Hakimsons Private Limited is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 15 product registrations across 18 distinct molecules. Its portfolio is concentrated in Immune Sera And Immunoglobulins and Vaccine. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Top molecules by brand count

Irinotecan3 brands
Measles, Mumps And Rubella Vaccine1 brand
Mumps1 brand
Measles1 brand
Anti-D Immunoglobulin1 brand

Therapeutic classes

Immune Sera And Immunoglobulins · 6Vaccine · 3Antihaemorrhagic · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official5 products · Rs 4,062.12 – Rs 53,554.97
Median across source: Rs 13,543.18

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

SIND MEDICAL STORES8 shared molecules
AMSON6 shared molecules
HAKIMSONS IMPEX (PVT) LTD.6 shared molecules
POPULAR5 shared molecules
BIOTEST/NABIQASIM4 shared molecules
GENE-TECH LABORATORIES3 shared molecules

Get the full profile for Hakimsons

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.